In the BioHarmony Drug Report Database

"Preview" Icon

Methylprednisolone

Medrol (methylprednisolone) is a small molecule pharmaceutical. Methylprednisolone was first approved as Medrol on 1982-01-01. It is used to treat adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, and berylliosis amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor. In addition, it is known to target short transient receptor potential channel 5.

 

Trade Name

 

Medrol
 

Common Name

 

methylprednisolone
 

ChEMBL ID

 

CHEMBL650
 

Indication

 

adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, berylliosis, brain neoplasms, dermatitis herpetiformis, erythema multiforme, graft vs host disease, hematologic diseases, hypercalcemia, inflammation, leukemia, multiple sclerosis, mycosis fungoides, nephrotic syndrome, neurologic manifestations, pemphigus, pulmonary tuberculosis, respiratory distress syndrome, rheumatic diseases, sarcoidosis, serum sickness, synovitis, systemic lupus erythematosus, thyroiditis, ulcerative colitis, uveitis
 

Drug Class

 

Prednisone and prednisolone derivatives

Image (chem structure or protein)

Methylprednisolone structure rendering